Lauren S. Page

Two cases of pregnancy during the fourth year of 68 mg etonogestrel implant use

PURPOSE: The United States Food and Drug Administration recently expanded approval of the 68 mg radiopaque etonogestrel (ENG) contraceptive implant (Nexplanon, Organon, Oss, The Netherlands) from three years to five years, based on clinical trial data showing no pregnancies in ye...